Caas Capital Management LP Novavax Inc Call Options Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 13, 2022
SELL
$69.73 - $142.9 $2.71 Million - $5.54 Million
-38,800 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$121.0 - $257.67 $1.36 Million - $2.89 Million
-11,200 Reduced 22.4%
38,800 $8.24 Million
Q1 2021

May 17, 2021
BUY
$112.98 - $319.93 $5.65 Million - $16 Million
50,000 New
50,000 $9.07 Million

Others Institutions Holding NVAX

# of Institutions
286
Shares Held
84.8M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $713M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email